$BCRX news
The latest BCRX stock news: headlines, filings, AI summaries and sentiment for $BCRX, updated around the clock.
- BIOCRYST PHARMACEUTICALS INC - 10-Q Filing
- BioCryst Pharmaceuticals Provides 2026 Operating Expense and ORLADEYO Revenue Guidance
- BioCryst Reports Strong Q3 2026 Results Driven by Orladeyo Sales Growth
- BioCryst Pharmaceuticals Reports Q3 Earnings Beat on Strong Revenue Growth
- BIOCRYST PHARMACEUTICALS INC - 8-K Filing
- FDA Approves Oral Pellet Formulation of BioCryst's Orladeyo
- BioCryst (BCRX) Posts First Profit and Eyes Expansion Through Rare Disease Acquisitions
- BioCryst Becomes Profitable and Seeks to Expand in Rare Disease Drug Market
- UnitedHealth Group Reports Strong Q1 Earnings and Revenue Beats
- BioCryst Pharmaceuticals Stock Rises Amid Rare Disease Growth and Institutional Buying
- BioCryst Reports Q1 2026 Earnings with Revenue Growth and Operational Updates
- BioCryst Pharmaceuticals Reports Q1 2026 Earnings Call Details
- BioCryst Pharmaceuticals Reports Q1 Earnings with Strong ORLADEYO Performance
- Oruka Therapeutics Shares Rise on Positive Clinical Trial Results for Psoriasis Treatment